Cancer treatment method
An object of the present invention is to provide a formulation that avoids an induction of inflammatory cytokine production caused by drugs when suppressing the progression, suppressing recurrence and/ or treating the cancer by the STING-acting compound. The present invention relates to a formulatio...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | An object of the present invention is to provide a formulation that avoids an induction of inflammatory cytokine production caused by drugs when suppressing the progression, suppressing recurrence and/ or treating the cancer by the STING-acting compound. The present invention relates to a formulation in which a STING-agonizing compound is administered in combination with a corticosteroid during cancer progression suppression, recurrence suppression and / or treatment, and a method of avoiding induction of inflammatory cytokine production by prescribing a reduced dose of a STING agonist compound in combination with an antineoplastic agent and further in combination with a corticosteroid. |
---|